Work

Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)

Year: 2003

Type: article

Study design: Clinical Trial

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2003.10.011

Authors: Gregory A Otterson, James E Herndon, Dorothy Watson, Mark R Green, Hedy L Kindler

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Medical University of South Carolina, University of Chicago Medical Center

Language: English

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G10814802, G1391839138, WUMC Cancer and Leukemia Group B, G1486637521, G1689128559, G199746015, G20154349, G257334932, G2647518335, Cancer and Leukemia Group B Statistical Center, University of Iowa CALGB Institutional Grant, Southeast Cancer Control Consortium, Inc, G3710026009, G4530377164, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, Delaware/Christiana Care Community Clinical Oncology Program, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, G6886639697, CANCER CENTER CALGB PARTICIPATION, G739544170, CANCER AND LEUKEMIA GROUP B--MINNESOTA ONCOLOGY GROUP, Cancer and Leukemia Group B, Cancer and Leukemia Group B - The Ohio State University, Nevada Cancer Research foundation-Community Clinical Oncology Program, CANCER AND LEUKEMIA GROUP B, G877081928, G877907214, G926666752, G973482110, G979369470

OpenAlex ID: W1993568439

FWCI: 11.61

Cites: 58

Cited by: 106

Related to: 10